KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Non-Current Assets (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Non-Current Assets for 11 consecutive years, with -$520.8 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Non-Current Assets changed N/A year-over-year to -$520.8 million, compared with a TTM value of $594.2 million through Jun 2025, changed N/A, and an annual FY2024 reading of $1.1 billion, up 0.81% over the prior year.
  • Non-Current Assets was -$520.8 million for Q2 2025 at Medpace Holdings, down from $1.1 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.1 billion in Q1 2025 and bottomed at -$1.0 billion in Q3 2024.
  • Average Non-Current Assets over 5 years is $779.9 million, with a median of $989.5 million recorded in 2022.
  • The sharpest move saw Non-Current Assets rose 9.99% in 2021, then crashed 199.49% in 2024.
  • Year by year, Non-Current Assets stood at $969.0 million in 2021, then grew by 5.11% to $1.0 billion in 2022, then increased by 4.37% to $1.1 billion in 2023, then increased by 0.81% to $1.1 billion in 2024, then plummeted by 148.6% to -$520.8 million in 2025.
  • Business Quant data shows Non-Current Assets for MEDP at -$520.8 million in Q2 2025, $1.1 billion in Q1 2025, and $1.1 billion in Q4 2024.